Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited
GZPHF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $2,775 | $19,361 | $22,473 | $15,933 |
| % Growth | -85.7% | -13.8% | 41.1% | – |
| Cost of Goods Sold | $2,328 | $16,308 | $17,864 | $13,869 |
| Gross Profit | $447 | $3,053 | $4,610 | $2,064 |
| % Margin | 16.1% | 15.8% | 20.5% | 13% |
| R&D Expenses | $22 | $142 | $144 | $185 |
| G&A Expenses | $0 | -$338 | $606 | -$1,191 |
| SG&A Expenses | $270 | -$682 | $2,193 | -$2,990 |
| Sales & Mktg Exp. | $0 | -$345 | $1,587 | -$1,799 |
| Other Operating Expenses | $12 | $2,795 | $46 | $5,273 |
| Operating Expenses | $304 | $2,254 | $2,382 | $2,468 |
| Operating Income | $143 | $799 | $2,227 | -$405 |
| % Margin | 5.2% | 4.1% | 9.9% | -2.5% |
| Other Income/Exp. Net | $11 | $60 | $4 | $6 |
| Pre-Tax Income | $154 | $859 | $2,231 | -$398 |
| Tax Expense | $38 | $141 | $374 | -$110 |
| Net Income | $111 | $695 | $1,821 | -$323 |
| % Margin | 4% | 3.6% | 8.1% | -2% |
| EPS | 0.069 | 0.43 | 1.12 | -0.2 |
| % Growth | -84.1% | -61.6% | 660% | – |
| EPS Diluted | 0.069 | 0.43 | 1.12 | -0.2 |
| Weighted Avg Shares Out | 1,626 | 1,626 | 1,626 | 1,626 |
| Weighted Avg Shares Out Dil | 1,626 | 1,626 | 1,626 | 1,626 |
| Supplemental Information | – | – | – | – |
| Interest Income | $17 | $37 | $48 | $81 |
| Interest Expense | $14 | $102 | $102 | $101 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | $168 | $962 | $2,333 | -$298 |
| % Margin | 6% | 5% | 10.4% | -1.9% |